Fundamental dimension Equity attribute | CYLCPeer $0.00010.00% Cap $8.14KP/E -0.0x QuantScore35/100 | AATGFPeer $0.0450.00% Cap $2.90MP/E -2.7x QuantScore24/100 | ASNCFLeader $0.240.00% Cap $24.04MP/E 10.6x QuantScore49/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
55/100 |
39/100 |
23/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 33/100 | 100/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 23/100 | 69/100 |
Growth Revenue / earnings growth & margins | 33/100 | 0/100 | 6/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -2.7x | 10.6x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -33.1x | -9.8x | 0.5x |
Price / Sales | — | 2.0x | 0.2x |
Price / Free Cash Flow | — | -5.8x | -14.0x |
PEG ratio | 0.00 | 0.01 | 0.49 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 3 / 9 | 6 / 9 |
Altman Z-Score | -92.06 (Distress) | -93.66 (Distress) | 3.41 (Safe) |
Total debt / equity | -0.51 | -0.27 | 0.03 |
Quick ratio | 0.0x | 0.1x | 2.0x |
Interest coverage | -0.4x | -3.3x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -100.0% | -16.8% | -16.5% |
Net income growth YoY | +63.6% | -150.9% | +5.2% |
Gross margin (TTM) | 0.0% | -3.5% | 3.7% |
Operating margin (FY) | — | -72.4% | 1.2% |
FCF margin (FY) | — | -35.2% | 1.1% |
5. Trailing price performancePrice change over period |
1M return | +0.0% | 0.0% | 0.0% |
3M return | +0.0% | 0.0% | 0.0% |
6M return | -95.0% | 0.0% | 0.0% |
Year to date | -95.0% | 0.0% | 0.0% |
1Y return | -95.0% | 0.0% | +0.4% |
3Y return | -97.8% | +74900.0% | -7.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0175 -17593.1% premium | $-0.071 -257.8% premium | $0.6371 +165.5% upside |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |